Research Output per year
Research Output 2004 2019
2017
14
Citations
(Scopus)
Treatment strategies for DNA repair-deficient prostate cancer
Teply, B. A. & Antonarakis, E. S., Aug 3 2017, In : Expert Review of Clinical Pharmacology. 10, 8, p. 889-898 10 p.Research output: Contribution to journal › Review article
DNA Repair-Deficiency Disorders
Prostatic Neoplasms
DNA Repair
Neoplasms
Therapeutics
2016
8
Citations
(Scopus)
Novel mechanism-based therapeutics for androgen axis blockade in castration-resistant prostate cancer
Teply, B. A. & Antonarakis, E. S., Jun 1 2016, In : Current Opinion in Endocrinology, Diabetes and Obesity. 23, 3, p. 279-290 12 p.Research output: Contribution to journal › Review article
Castration
Androgens
Prostatic Neoplasms
Androgen Receptor Antagonists
Pharmaceutical Preparations
2014
44
Citations
(Scopus)
Identification and management of toxicities from immune checkpoint-blocking drugs
Teply, B. A. & Lipson, E. J., Nov 1 2014, In : Oncology (Williston Park, N.Y.). 28, p. 30-38 9 p.Research output: Contribution to journal › Review article
Pharmaceutical Preparations
Practice Guidelines
Antineoplastic Agents
Neoplasms
Therapeutics
11
Citations
(Scopus)
Systemic therapy for bladder cancer - a medical oncologist's perspective
Teply, B. A. & Kim, J. J., Jan 1 2014, In : Journal of Solid Tumors. 4, 2, p. 25-35 11 p.Research output: Contribution to journal › Review article
Urinary Bladder Neoplasms
Cisplatin
gemcitabine
Vinblastine
Methotrexate
2006
5
Citations
(Scopus)
Nanoparticle-aptamer bioconjugates for targeted antineoplastic drug delivery
Teply, B. A., Rocha, F. G., Levy-Nissenbaum, E., Langer, R. & Farokhzad, O. C., Sep 12 2006, In : American Journal of Drug Delivery. 4, 3, p. 123-130 8 p.Research output: Contribution to journal › Review article
Antineoplastic Agents
Nanoparticles
docetaxel
Neoplasms
Pharmaceutical Preparations